GlassScriptPhysician profile
David Alfred Sitzes
NPI 1336107010
$225.55
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.01 · 2020: $116 · 2021: $39.57 · 2022: $13.37.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $53.99 | 2019-2020 | |
| Glaxosmithkline, LLC. | $36.50 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $32.45 | 2019-2020 | |
| Genentech USA, INC. | $27.98 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.49 | 2020 | |
| Novo Nordisk INC | $15.71 | 2020 | |
| Pfizer INC. | $15.03 | 2020 | |
| Allergan, INC. | $12.52 | 2019 | |
| Grifols USA, LLC | $11.88 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sitzes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.